EXACT Therapeutics AS: Primary insider notices
EXACT Therapeutics AS (EXTX) · publisert 2021-06-07 08:02 · vis på NewsWeb
Transaksjoner
| Person | Rolle | Type | Volum | Pris | Dato | ISIN | Handelsplass | Tolket via |
|---|---|---|---|---|---|---|---|---|
| Aitana Peire Morais 2 a) Position/status The notification concerns a Primary insider: Aitana Peire Morais, PhD, Director of Board | The notification concerns a Primary insider: Aitana Peire Morais, PhD, Director of Board | acquisition | 5 030 | 20,804 | 2021-06-04 | – | MERK – Oslo Børs | rules |
| Hans Henrik Klouman 2 a) Position/status The notification concerns a Primary insider: Hans Henrik Klouman, Board member, Lawyer | The notification concerns a Primary insider: Hans Henrik Klouman, Board member, Lawyer | acquisition | 2 900 | 20,804 | 2021-06-04 | – | MERK – Oslo Børs | rules |
| William Castell 2 a) Position/status The notification concerns a Primary insider: William Castell, LVO FMedSci, Vice-Chair of Board | The notification concerns a Primary insider: William Castell, LVO FMedSci, Vice-Chair of Board | acquisition | 9 998 | 20,804 | 2021-06-04 | – | MERK – Oslo Børs | rules |
| Masha Strømme 2 a) Position/status The notification concerns a Primary insider: Masha Strømme, PhD, Chair of Board | The notification concerns a Primary insider: Masha Strømme, PhD, Chair of Board | acquisition | 6 489 | 20,804 | 2021-06-04 | – | MERK – Oslo Børs | rules |
Vedlegg
- Notification of transactions by Primary Insider Aitana P Morais.pdf (tekst hentet ut)
- Notification of transactions by Primary Insider Hans H Kloumann.pdf (tekst hentet ut)
- Notification of transactions by Primary Insider William Castell.pdf (tekst hentet ut)
- Notification of transactions by Primary Insider Masha Strømme.pdf (tekst hentet ut)
Meldingstekst
Oslo, 7 June 2021: Reference is made to the stock exchange release by EXACT Therapeutics AS ("EXACT-Tx" or the "Company") on 7 June 2021 regarding a share capital increase in connection with the Company's restricted stock unit (RSU) programme.
Masha Strømme, chair of EXACT-Tx, has through her majority owned company PAACS Invest AS, subscribed for 6,489 shares at NOK 20.804 per share. Following this transaction, Masha Strømme will hold 2,684,739 shares in EXACT-Tx through PAACS Invest AS.
Sir William Castell, vice-chair of EXACT-Tx, has subscribed for 9,998 shares at NOK 20.804 per share. Following this transaction, Sir William Castell will hold 342,498 shares in EXACT-Tx.
Hans Henrik Klouman, board member of EXACT-Tx, has subscribed for 2,900 shares at NOK 20.804 per share. Following this transaction, Hans Henrik Klouman will hold 402,650 shares in EXACT-Tx through Virkelyst AS.
Aitana Peire, board member of EXACT-Tx, has subscribed for 5,030 shares at NOK 20.804 per share. Following this transaction, Aitana Peire will hold 5030 shares in EXACT-Tx.
About EXACT-Tx
EXACT-Tx is a clinical stage Norwegian biotech company developing a technology platform for targeted therapeutic enhancement – Acoustic Cluster Therapy (ACT®). ACT® sonoporation is a unique approach to ultrasound-mediated, targeted drug enhancement – with the potential to significantly amplify the clinical utility of a wide range of therapeutic agents across a multitude of indications including within oncology (chemotherapy, immunotherapy), infectious diseases, and neurological conditions. www.exact-tx.com